Moderna Faces Global Patent Litigation over COVID-19 Vaccine Technology

Moderna is currently facing legal challenges regarding its COVID-19 vaccine, as Arbutus Biopharma and Genevant Sciences have filed lawsuits against the pharmaceutical giant. These companies have expanded their litigation efforts globally, alleging patent infringement in several jurisdictions, including Canada, Japan, Switzerland, and the Unified Patent Court. These cases center around claims that Moderna’s mRNA technology, a cornerstone of its COVID-19 vaccine, violates patents held by the plaintiffs. As these legal proceedings advance, they could have significant implications for the pharmaceutical industry and intellectual property rights concerning vaccine technology.